Comparison of two different treat-and-extend protocols with aflibercept in wet age-related macular degeneration.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To optimize the aflibercept treat-and-extend protocol in wet age-related macular degeneration (wAMD).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Acta Ophthalmol

Title: Acta ophthalmologica

Publisher: Wiley

ISSN (Electronic): 1755-3768

ISSN (Print): 1755-375X

Publication date (Electronic): May 2020

Volume: 98

Issue: 3

Affiliations

[1 ] Helsinki Retina Research Group, University of Helsinki, Helsinki, Finland.

[2 ] Department of Ophthalmology, Helsinki University Hospital, Helsinki, Finland.

[3 ] Department of Ophthalmology, Kymenlaakso Central Hospital, Kotka, Finland.

Article

DOI: 10.1111/aos.14231

PubMed ID: 31421024

SO-VID: 8b9d5df9-4263-459d-acf0-6e06a6dcde4d

History

Keywords: aflibercept,anti-vascular endothelial growth factor,treat-and-extend regimen,wet age-related macular degeneration

Data availability:

Keywords: aflibercept, anti-vascular endothelial growth factor, treat-and-extend regimen, wet age-related macular degeneration

Comparison of two different treat-and-extend protocols with aflibercept in wet age-related macular degeneration.

Read this article at

Abstract

Related collections

ChemSpider related publications

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 5